> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# BD, BioGX Gets EUA for New Covid Test
- URL: https://www.fdaweb.com/bd-biogx-gets-eua-for-new-covid-test/
- Published: 2020-04-03T12:00:00.000Z
- Updated: 2026-09-14T16:09:56.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5146493

FDA has granted Becton, Dickinson and BioGX an emergency use authorization for a new diagnostic test that will enable hospitals to screen for Covid-19 ) on site and get results in under three hours. The test will be run on the BD Max System, a molecular diagnostic platform already in use at hundreds of laboratories in nearly every state across the country, according to the companies. Each unit is capable of analyzing hundreds of samples per day. The automated system is intended to reduce human error in testing and cumulatively the tests are expected to add capacity for 50,000 tests per week nationwide, they say. The assay is based on the same viral RNA targeting sequences and real-time polymerase chain reaction detection method as the test developed by the CDC.